Parkinson's Disease. Genetic Insights and Early Detection through DNA Testing.

It is characterised by the degeneration of specific neurons in the brain, leading to various motor and non-motor symptoms. Parkinson's disease (PD) is a chronic neurological disorder that affects millions of people worldwide.

Understanding the genetic basis of Parkinson's disease and using the power of DNA testing for early detection are vital steps towards effective management and potential future treatments.

In this blog, we explore what Parkinson's disease is, at what age it typically appears, its genetic components, and the significance of DNA testing in identifying the condition early on.

Early Disease Genetic DNA Testing

Parkinson's Disease: An Overview

Parkinson's disease is a progressive disorder that primarily affects the motor system, leading to symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability.

Additionally, non-motor symptoms such as depression, sleep disturbances, cognitive impairments, and autonomic dysfunction may also manifest in individuals with PD.

At Home DNA Testing

Onset Age and Prevalence

Parkinson's disease is most commonly diagnosed in individuals over the age of 60, and the risk increases with advancing age.

However, it is important to note that a small percentage of cases (approximately 5-10%) develop before the age of 50, known as early-onset PD.This form of PD is often associated with a stronger genetic component.

At Home Genetic DNA Testing

Genetic Factors and Parkinson's Disease

While the majority of Parkinson's disease cases are considered sporadic, with no clear genetic cause, an increasing body of research suggests that genetic factors play a significant role in the development of the disease.

Mutations in specific genes have been identified to be associated with an increased risk of developing Parkinson's disease.

Several genes have been linked to PD, including SNCA, LRRK2, Parkin, PINK1, and DJ-1, among others.

These genes are involved in crucial cellular processes such as protein degradation, mitochondrial function, and neurotransmitter regulation.

Mutations in these genes disrupt these processes, leading to the degeneration of dopaminergic neurons and subsequent development of Parkinson's disease symptoms.

At Home Genetic DNA Testing

Early Detection through DNA Testing

Advancements in DNA testing technologies have provided new avenues for early detection and risk assessment of Parkinson's disease.

Genetic testing allows individuals with a family history of PD or those experiencing early-onset symptoms to determine their genetic predisposition to the disease.

Genetic testing can identify mutations in specific genes associated with Parkinson's disease.

A comprehensive genetic analysis can help healthcare professionals assess the individual's risk, guide treatment decisions, and enable early interventions.

For individuals identified as high-risk, regular monitoring and targeted interventions can be implemented to potentially delay or mitigate the onset of symptoms.

At Home Genetic DNA Counselling

Parkinson's disease is a complex disorder with both genetic and environmental influences. The advent of DNA testing has provided opportunities for early detection and risk assessment, enabling individuals at high risk to make informed decisions about their health and potentially access interventions that may delay the onset of symptoms.

CircleDNA Trust Pilot Reviews


Lesage, S., & Brice, A. (2009). Parkinson's disease: From monogenic forms to genetic susceptibility factors. Human Molecular Genetics, 18(R1), R48-R59.

Puschmann, A. (2017). Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations. Parkinsonism & Related Disorders, 44, 1-11.

Klein, C., & Westenberger, A. (2012). Genetics of Parkinson's disease. Cold Spring Harbor Perspectives in Medicine, 2(1), a008888.

Houlden, H., Singleton, A. B., & The GENDEC and PARKGEN Consortia. (2012). The genetics and neuropathology of Parkinson's disease. Acta Neuropathologica, 124(3), 325-338.

* Please note that at Parkside Designs Art we are not doctors or scientists. The information in this blog is informative only. We accept no liability in any form for the information provided.

CircleDNA Discount Code

Thanks for reading our blog. We hope it's been beneficial for you. If you think it could benefit someone you know, then please feel free to share.

Parkside Designs Art

Kim - Personal Assistant To The Creative Director - Josh


Leave a comment